tradingkey.logo

Bausch + Lomb Corp

BLCO
17.000USD
+0.590+3.60%
終値 02/06, 16:00ET15分遅れの株価
6.02B時価総額
損失額直近12ヶ月PER

Bausch + Lomb Corp

17.000
+0.590+3.60%

詳細情報 Bausch + Lomb Corp 企業名

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corpの企業情報

企業コードBLCO
会社名Bausch + Lomb Corp
上場日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)
従業員数13500
証券種類Ordinary Share
決算期末May 06
本社所在地520 Applewood Crescent
都市VAUGHAN
証券取引所NASDAQ OMX NASDAQ Basic NYSE
Canada
郵便番号L4K 4B4
電話番号19082552864
ウェブサイトhttps://ir.bausch.com/
企業コードBLCO
上場日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)

Bausch + Lomb Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+6146.00%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+17715.00%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
66.56K
+1642.00%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
52.37K
+35034.00%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+6146.00%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+17715.00%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
66.56K
+1642.00%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
52.37K
+35034.00%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Devices
484.00M
37.78%
OTC
454.00M
35.44%
Pharmaceuticals
280.00M
21.86%
Branded and other Generics
59.00M
4.61%
Other revenues
4.00M
0.31%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Devices
484.00M
37.78%
OTC
454.00M
35.44%
Pharmaceuticals
280.00M
21.86%
Branded and other Generics
59.00M
4.61%
Other revenues
4.00M
0.31%

株主

更新時刻: Sat, Nov 22
更新時刻: Sat, Nov 22
株主統計
種類
株主統計
株主統計
比率
Bausch Health Companies Inc
87.62%
Icahn Enterprises LP
0.99%
Deutsche Bank Securities Inc.
0.99%
Alberta Investment Management Corporation
0.92%
Oaktree Capital Management, L.P.
0.92%
他の
8.56%
株主統計
株主統計
比率
Bausch Health Companies Inc
87.62%
Icahn Enterprises LP
0.99%
Deutsche Bank Securities Inc.
0.99%
Alberta Investment Management Corporation
0.92%
Oaktree Capital Management, L.P.
0.92%
他の
8.56%
種類
株主統計
比率
Corporation
87.62%
Hedge Fund
3.73%
Investment Advisor/Hedge Fund
3.02%
Research Firm
1.67%
Investment Advisor
1.62%
Holding Company
0.99%
Sovereign Wealth Fund
0.92%
Individual Investor
0.48%
Family Office
0.24%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
247
42.63M
17.16%
+11.66K
2025Q3
260
42.62M
19.43%
+3.57M
2025Q2
253
39.09M
18.05%
+715.03K
2025Q1
249
38.33M
16.53%
-19.93M
2024Q4
239
35.61M
16.96%
-2.09M
2024Q3
234
37.72M
16.36%
-3.49M
2024Q2
237
40.61M
17.42%
+3.09M
2024Q1
226
37.49M
18.08%
-25.96M
2023Q4
216
38.90M
17.69%
-4.13M
2023Q3
198
43.02M
17.49%
-1.91M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Bausch Health Companies Inc
310.45M
87.65%
--
--
Mar 24, 2025
Icahn Enterprises LP
3.50M
0.99%
--
--
Sep 30, 2025
Deutsche Bank Securities Inc.
3.50M
0.99%
+89.90K
+2.64%
Sep 30, 2025
Alberta Investment Management Corporation
3.27M
0.92%
+258.00K
+8.58%
Mar 31, 2025
Oaktree Capital Management, L.P.
3.25M
0.92%
+724.19K
+28.72%
Sep 30, 2025
GoldenTree Asset Management, LP
2.66M
0.75%
+77.32K
+2.99%
Sep 30, 2025
D. E. Shaw & Co., L.P.
2.61M
0.74%
--
--
Sep 30, 2025
Silver Point Capital, L.P.
2.56M
0.72%
+2.56M
--
Sep 30, 2025
Fidelity Management & Research Company LLC
1.56M
0.44%
+788.29K
+102.13%
Sep 30, 2025
Glenview Capital Management, LLC
1.55M
0.44%
--
--
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Ballast Small/Mid Cap ETF
1.4%
Invesco RAFI Developed Mkts ex-US SM ETF
0.03%
BNY Mellon US Small Cap Core Equity ETF
0.03%
Schwab Fundamental International Small Equity ETF
0%
Goldman Sachs MarketBeta US 1000 Equity ETF
0%
Invesco Zacks Mid-Cap ETF
0%
QRAFT AI-Enhanced US Large Cap ETF
0%
AltShares Event-Driven ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
BNY Mellon US Mid Cap Core Equity ETF
0%
詳細を見る
Ballast Small/Mid Cap ETF
比率1.4%
Invesco RAFI Developed Mkts ex-US SM ETF
比率0.03%
BNY Mellon US Small Cap Core Equity ETF
比率0.03%
Schwab Fundamental International Small Equity ETF
比率0%
Goldman Sachs MarketBeta US 1000 Equity ETF
比率0%
Invesco Zacks Mid-Cap ETF
比率0%
QRAFT AI-Enhanced US Large Cap ETF
比率0%
AltShares Event-Driven ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
BNY Mellon US Mid Cap Core Equity ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI